Compound ID | 1241

Update compound information

TopESKAPE

Class: Bacterial topoisomerase inhibitor

Spectrum of activity: Gram-negative
Details of activity: Treatment of infections due to bacteria with established or emerging resistance including MDR isolates
Institute where first reported: Idorsia
Highest developmental phase: Preclinical
Development status: Active
External links:
Citation: https://carb-x.org/carb-x-news/carb-x-funds-idorsia-to-accelerate-the-early-development-of-a-new-class-of-antibiotic-to-treat-deadly-drug-resistant-bacterial-infections/

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.